Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totaling 94,200 shares, a growth of 76.1% from the September 15th total of 53,500 shares. Currently, 4.2% of the shares of the stock are sold short. Based on an average daily volume of 2,980,000 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 2,980,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 4.2% of the shares of the stock are sold short.

Aethlon Medical Stock Performance

AEMD stock opened at $5.51 on Tuesday. The company has a market capitalization of $14.33 million, a PE ratio of -0.44 and a beta of 1.82. Aethlon Medical has a one year low of $5.00 and a one year high of $84.40. The company’s 50 day moving average price is $9.83 and its two-hundred day moving average price is $17.82.

Aethlon Medical (NASDAQ:AEMD) last posted its quarterly earnings results on Wednesday, August 13th. The medical equipment provider reported ($8.50) EPS for the quarter, missing the consensus estimate of ($6.80) by ($1.70). On average, research analysts predict that Aethlon Medical will post -0.73 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on AEMD. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aethlon Medical in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Aethlon Medical to a “sell” rating in a research note on Saturday, August 30th. Finally, HC Wainwright reaffirmed a “neutral” rating on shares of Aethlon Medical in a research note on Thursday, August 14th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $560.00.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Aethlon Medical stock. Armistice Capital LLC bought a new position in Aethlon Medical, Inc. (NASDAQ:AEMD) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,427,946 shares of the medical equipment provider’s stock, valued at approximately $511,000. Armistice Capital LLC owned 8.89% of Aethlon Medical as of its most recent SEC filing. Institutional investors own 1.99% of the company’s stock.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.